Switchability of Neoral and Equoral According to Food and Drug Administration Rules and Regulations-Reference-Cited by-同舟云学术

Switchability of Neoral and Equoral According to Food and Drug Administration Rules and Regulations

Published:2005-09 Issue:7 Volume:37 Page:2988-2993
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Masri M.A.,Haberal M.,Rizvi A.,Stephan A.,Bilgin N.,Naqvi A.,Barbari A.,Kamel G.,Zafar N.,Emiroğlu R.,Çolak T.,Manzoor K.,Matha V.,Kamarad V.,Rost M.,Rizk S.,Hazime A.,Perlik F.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference29 articles.

1. Cyclosporine formulations;Masri;Transplant Proc,2000

2. Safe and cost effective conversion from Neoral to Consupren soft gelatin capsules in stable renal transplant patients;Masri;Transplant Proc,1999

3. A one-year comparative study of Neoral vs Consupren in de novo renal transplant patients;Stephan;Transplant Proc,1998

4. Experience with new cyclosporine formulations;Barbari;Transplant Proc,1997

5. Evaluation of the new cyclosporine formulation, Consupren, in renal transplant patients;Stephan;Transplant Proc,1996

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants;BMC Nephrology;2019-05-14

2. Generic immunosuppressants;Pediatric Nephrology;2017-07-21

3. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis;BMJ;2015-06-22

4. Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars;Nanomedicine;2015-03

5. The use of ciclosporin A in veterinary dermatology;The Veterinary Journal;2012-08